FDA Eyes New Trial Designs, Studies On Lower Doses To Speed Vaccines

By Kelly Lienhard / January 11, 2021 at 2:59 PM
FDA Chief Stephen Hahn told reporters on Friday (Jan. 8) that the agency is working with the White House and industry to figure out how to increase availability of and speed up administration of COVID-19 vaccines, including by testing whether vaccines are effective at lower doses and considering novel clinical trial designs that would assess different vaccine dosing and administration methods. In recent weeks, government officials and healthy policy experts have floated ideas concerning alternative vaccine dosing strategies to get...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.